Literature DB >> 29101234

Periodic variation in bile acids controls circadian changes in uric acid via regulation of xanthine oxidase by the orphan nuclear receptor PPARα.

Takumi Kanemitsu1, Yuya Tsurudome1, Naoki Kusunose1, Masayuki Oda1, Naoya Matsunaga1,2, Satoru Koyanagi1,2, Shigehiro Ohdo3.   

Abstract

Xanthine oxidase (XOD), also known as xanthine dehydrogenase, is a rate-limiting enzyme in purine nucleotide degradation, which produces uric acid. Uric acid concentrations in the blood and liver exhibit circadian oscillations in both humans and rodents; however, the underlying mechanisms remain unclear. Here, we demonstrate that XOD expression and enzymatic activity exhibit circadian oscillations in the mouse liver. We found that the orphan nuclear receptor peroxisome proliferator-activated receptor-α (PPARα) transcriptionally activated the mouse XOD gene and that bile acids suppressed XOD transactivation. The synthesis of bile acids is known to be under the control of the circadian clock, and we observed that the time-dependent accumulation of bile acids in hepatic cells interfered with the recruitment of the co-transcriptional activator p300 to PPARα, thereby repressing XOD expression. This time-dependent suppression of PPARα-mediated transactivation by bile acids caused an oscillation in the hepatic expression of XOD, which, in turn, led to circadian alterations in uric acid production. Finally, we also demonstrated that the anti-hyperuricemic effect of the XOD inhibitor febuxostat was enhanced by administering it at the time of day before hepatic XOD activity increased. These results suggest an underlying mechanism for the circadian alterations in uric acid production and also underscore the importance of selecting an appropriate time of day for administering XOD inhibitors.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  bile acid; circadian rhythm; nucleoside/nucleotide metabolism; peroxisome proliferator–activated receptor (PPAR); uric acid; xanthine oxidase

Mesh:

Substances:

Year:  2017        PMID: 29101234      PMCID: PMC5766946          DOI: 10.1074/jbc.M117.791285

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Circadian transcription of the cholesterol 7 alpha hydroxylase gene may involve the liver-enriched bZIP protein DBP.

Authors:  D J Lavery; U Schibler
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

2.  mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop.

Authors:  K Kume; M J Zylka; S Sriram; L P Shearman; D R Weaver; X Jin; E S Maywood; M H Hastings; S M Reppert
Journal:  Cell       Date:  1999-07-23       Impact factor: 41.582

3.  Purine and pyrimidine salvage in whole rat brain. Utilization of ATP-derived ribose-1-phosphate and 5-phosphoribosyl-1-pyrophosphate generated in experiments with dialyzed cell-free extracts.

Authors:  Catia Barsotti; Maria G Tozzi; Piero L Ipata
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

4.  Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

Authors:  Marilda Mazzali; John Kanellis; Lin Han; Lili Feng; Yi-Yang Xia; Qiang Chen; Duk-Hee Kang; Katherine L Gordon; Susumu Watanabe; Takahiko Nakagawa; Hui Y Lan; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2002-06

Review 5.  Uridine and cytidine in the brain: their transport and utilization.

Authors:  Mehmet Cansev
Journal:  Brain Res Rev       Date:  2006-09

6.  CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARalpha) in mice.

Authors:  Katsutaka Oishi; Hidenori Shirai; Norio Ishida
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

7.  Uric acid levels and dopamine transmission in rat striatum: diurnal changes and effects of drugs.

Authors:  R D O'Neill
Journal:  Brain Res       Date:  1990-01-22       Impact factor: 3.252

Review 8.  Pleiotropic roles of bile acids in metabolism.

Authors:  Thomas Q de Aguiar Vallim; Elizabeth J Tarling; Peter A Edwards
Journal:  Cell Metab       Date:  2013-04-18       Impact factor: 27.287

9.  Bile acid-regulated peroxisome proliferator-activated receptor-α (PPARα) activity underlies circadian expression of intestinal peptide absorption transporter PepT1/Slc15a1.

Authors:  Ayako Okamura; Satoru Koyanagi; Adila Dilxiat; Naoki Kusunose; Jia Jun Chen; Naoya Matsunaga; Shigenobu Shibata; Shigehiro Ohdo
Journal:  J Biol Chem       Date:  2014-07-11       Impact factor: 5.157

10.  Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats.

Authors:  Edilia Tapia; Magdalena Cristóbal; Fernando E García-Arroyo; Virgilia Soto; Fabiola Monroy-Sánchez; Ursino Pacheco; Miguel A Lanaspa; Carlos A Roncal-Jiménez; David Cruz-Robles; Takuji Ishimoto; Magdalena Madero; Richard J Johnson; Laura-Gabriela Sánchez-Lozada
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-09
View more
  7 in total

1.  Peroxisome proliferator-activated receptor A/G reprogrammes metabolism associated with lipid accumulation in macrophages.

Authors:  Guozhu Ye; Han Gao; Yi Lin; Dongxiao Ding; Xu Liao; Han Zhang; Yulang Chi; Sijun Dong
Journal:  Metabolomics       Date:  2019-03-04       Impact factor: 4.290

2.  Pathway-level analysis of genome-wide circadian dynamics in diverse tissues in rat and mouse.

Authors:  Alison Acevedo; Panteleimon D Mavroudis; Debra DuBois; Richard R Almon; William J Jusko; Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-03-25       Impact factor: 2.745

3.  Zishen Qingre Tongluo Formula Improves Renal Fatty Acid Oxidation and Alleviated Fibrosis via the Regulation of the TGF-β1/Smad3 Signaling Pathway in Hyperuricemic Nephrology Rats.

Authors:  Peng Liu; Chen Wang; Yun Wang; Honghong Zhang; Baoli Liu; Xinping Qiu
Journal:  Biomed Res Int       Date:  2021-12-13       Impact factor: 3.411

Review 4.  Cholecystectomy as a risk factor for metabolic dysfunction-associated fatty liver disease: unveiling the metabolic and chronobiologic clues behind the bile acid enterohepatic circulation.

Authors:  Li Qi; Wanlin Dai; Jing Kong; Yu Tian; Yongsheng Chen
Journal:  J Physiol Biochem       Date:  2021-07-24       Impact factor: 4.158

Review 5.  Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease.

Authors:  Anca D Petrescu; Jessica Kain; Victoria Liere; Trace Heavener; Sharon DeMorrow
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-12       Impact factor: 5.555

6.  Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice.

Authors:  Yingjie Guo; Yanan Yu; Hailong Li; Xueli Ding; Xiaoyu Li; Xue Jing; Jianwei Chen; Guilin Liu; Yuan Lin; Chen Jiang; Zhen Liu; Yuwei He; Changgui Li; Zibin Tian
Journal:  Eur J Nutr       Date:  2020-10-26       Impact factor: 5.614

7.  N-Butyrylated hyaluronic acid ameliorates gout and hyperuricemia in animal models.

Authors:  Lanzhou Li; Di Wang; Xueju Wang; Ruifeng Bai; Chunyu Wang; Yin Gao; Tassos Anastassiades
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.